Alan P. Johnson – författare
Visar alla böcker från författaren Alan P. Johnson. Handla med fri frakt och snabb leverans.
3 produkter
3 produkter
Inbunden, Engelska, 2004
1 681 kr
Skickas inom 10-15 vardagar
An accessible introduction to how genomics has and will provide novel methods for bacterial investigation and advance our understanding and knowledge of bacterial pathogenicity. The authors critically evaluate the applications of genomics to diagnostic bacteriology, highlighting both current and likely future uses, describing real-time PCR methods, and outlining the promise of microarrays in clinical bacteriology. Their discussion examines in detail genomic approaches to antibacterial discovery, the nature of pathogenicity, the discovery of new pathogens, the exploration of the concept of clonality in bacteria, and bacterial taxonomics.
2 401 kr
Skickas
Internationally-renowned authors have prepared state-of-the-art review on the application of proteomic and genomic advances to clinical bacteriology. They cover the principles of bacterial genomics, the application of genomics to diagnostic bacteriology and protocols for interrogating bacterial genomes. This book will bring all clinical bacteriologists up-to-date with the significant advancements that genome sequencing has had on the field and enable them to turn these into tangible advances, with resulting benefits for patient care and management.
Häftad, Engelska, 2010
1 633 kr
Skickas inom 10-15 vardagar
Gazing into crystal balls is beyond the expertise of most scientists. Yet, as we look further into the 21st century, one does not have to be Nostradamus to predict that the current genomics and proteomics "revolution" will have an immense impact on medical bacteriology. This impact is already being re- ized in many academic departments, and although encroachment on routine diagnostic bacteriology, particularly in the hospital setting, is likely to occur at a slower pace, it remains nonetheless inevitable. Therefore, it is important that no one working in bacteriology should find themselves distanced from these fundamental developments. The involvement of all clinical bacteriologists is essential if the significant achievements of genome sequencing and analysis are to be turned into tangible advances, with resulting benefits for patient care and m- agement. It is our hope that Genomics, Proteomics, and Clinical Bacteriology: Methods and Reviews will play a part in bringing such a development to fruition. The advances in genomics and proteomics have already given us frequent opportunities to reassess our knowledge and understanding of established b- terial adversaries, and have provided us with the means to identify new foes. The new knowledge gained is enabling us to reconsider, for example, our c- cepts of bacterial pathogenicity, phylogeny and novel targets for antibacterial chemotherapy. These topics, and others, are considered in Genomics, Proteomics, and Clinical Bacteriology: Methods and Reviews.